Previous Article | Next Article 
Journal of Clinical Microbiology, September 1999, p. 2852-2857, Vol. 37, No. 9
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Monitoring of Epstein-Barr Virus DNA Load in
Peripheral Blood by Quantitative Competitive PCR
Servi J. C.
Stevens,1
Marcel B. H. J.
Vervoort,1
Adriaan J. C.
van den Brule,1,*
Pieter L.
Meenhorst,2
Chris J. L. M.
Meijer,1 and
Jaap M.
Middeldorp1,3
Department of Pathology, University Hospital
Vrije Universiteit,1 and Slotervaart
Hospital,2 Amsterdam, and Organon
Teknika, Boxtel,3 The Netherlands
Received 22 April 1999/Returned for modification 25 May
1999/Accepted 22 June 1999
A competitive quantitative PCR (Q-PCR) assay combined with simple
silica-based DNA extraction was developed for monitoring of
Epstein-Barr virus (EBV) DNA load in unfractionated peripheral blood.
The Q-PCR is based on competitive coamplification of a highly conserved
213-bp region of the EBNA-1 open reading frame with an internal
standard (IS), added in a known concentration. The IS has the same
amplicon length and base composition as the wild-type (WT) EBNA-1
amplicon but differs in 23 internally randomized bases. Competitive
coamplification yields two PCR products that are quantified by enzyme
immunoassay or by electrochemiluminescence detection, with probes
specific for the 23 differing internal nucleotides. The Q-PCR has a
sensitivity of 10 copies of either WT or IS plasmid DNA. The Q-PCR was
validated by quantification of known amounts of plasmid containing the
WT EBNA-1 target. Furthermore, we determined EBV genome copy numbers in
different cell lines. For EBV quantification in clinical samples, DNA
was isolated from lysed whole blood by silica-affinity purification.
Forty-six percent of healthy donor peripheral blood samples were
positive by Q-PCR. In most of these samples, viral load was less than
2,000 EBV copies/ml of blood. In peripheral blood samples from two
AIDS-related non-Hodgkin's lymphoma patients, elevated EBV loads (up
to 120,000 copies/ml) were observed, which decreased upon therapy. In
Burkitt's lymphoma patients, up to 4,592,000 EBV genome copies/ml of
blood were detected. In conclusion, the EBNA-1-based Q-PCR assay
provides a reproducible, accurate, and easy method for studying the
relationship between EBV load and clinical parameters.
*
Corresponding author. Mailing address: Department of
Pathology, University Hospital Vrije Universiteit, de Boelelaan
1117, 1081 HV Amsterdam, The Netherlands. Phone: 31204444023. Fax: 31204442964. E-mail: vandenbrule{at}azvu.nl.
Journal of Clinical Microbiology, September 1999, p. 2852-2857, Vol. 37, No. 9
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Hakim, H., Gibson, C., Pan, J., Srivastava, K., Gu, Z., Bankowski, M. J., Hayden, R. T.
(2007). Comparison of Various Blood Compartments and Reporting Units for the Detection and Quantification of Epstein-Barr Virus in Peripheral Blood. J. Clin. Microbiol.
45: 2151-2155
[Abstract]
[Full Text]
-
Conacher, M., Callard, R., McAulay, K., Chapel, H., Webster, D., Kumararatne, D., Chandra, A., Spickett, G., Hopwood, P. A., Crawford, D. H.
(2005). Epstein-Barr Virus Can Establish Infection in the Absence of a Classical Memory B-Cell Population. J. Virol.
79: 11128-11134
[Abstract]
[Full Text]
-
Stevens, S. J. C., Verkuijlen, S. A. W. M., Hariwiyanto, B., Harijadi, , Fachiroh, J., Paramita, D. K., Tan, I. B., Haryana, S. M., Middeldorp, J. M.
(2005). Diagnostic Value of Measuring Epstein-Barr Virus (EBV) DNA Load and Carcinoma-Specific Viral mRNA in Relation to Anti-EBV Immunoglobulin A (IgA) and IgG Antibody Levels in Blood of Nasopharyngeal Carcinoma Patients from Indonesia. J. Clin. Microbiol.
43: 3066-3073
[Abstract]
[Full Text]
-
Lit, L. C.W., Chan, K.C. A., Leung, S.-F., Lei, K. I.K., Chan, L. Y.S., Chow, K. C.K., Chan, A. T.C., Lo, Y.M. D.
(2004). Distribution of Cell-Free and Cell-Associated Epstein-Barr Virus (EBV) DNA in the Blood of Patients with Nasopharyngeal Carcinoma and EBV-Associated Lymphoma. Clin. Chem.
50: 1842-1845
[Full Text]
-
Andreone, P., Gramenzi, A., Lorenzini, S., Biselli, M., Cursaro, C., Pileri, S., Bernardi, M.
(2003). Posttransplantation Lymphoproliferative Disorders. Arch Intern Med
163: 1997-2004
[Abstract]
[Full Text]
-
Stevens, S. J. C., Verkuijlen, S. A. W. M., Brule, A. J. C. v. d., Middeldorp, J. M.
(2002). Comparison of Quantitative Competitive PCR with LightCycler-Based PCR for Measuring Epstein-Barr Virus DNA Load in Clinical Specimens. J. Clin. Microbiol.
40: 3986-3992
[Abstract]
[Full Text]
-
Woulfe, J. M., Duke, R., Middeldorp, J. M., Stevens, S., Vervoort, M., Hashimoto, M., Masliah, E., Chan, P., Di Monte, D. A., Langston, J. W., Petzinger, G., Hoogendoorn, H., Munoz, D. G.
(2002). Absence of elevated anti-{alpha}-synuclein and anti-EBV latent membrane protein antibodies in PD. Neurology
58: 1435-1435
[Full Text]
-
Lin, J.-C., Chen, K. Y., Wang, W.-Y., Jan, J.-S., Liang, W.-M., Tsai, C.-S., Wei, Y.-H.
(2001). Detection of Epstein-Barr Virus DNA in the Peripheral-Blood Cells of Patients With Nasopharyngeal Carcinoma: Relationship to Distant Metastasis and Survival. JCO
19: 2607-2615
[Abstract]
[Full Text]
-
Stevens, S. J. C., Pronk, I., Middeldorp, J. M.
(2001). Toward Standardization of Epstein-Barr Virus DNA Load Monitoring: Unfractionated Whole Blood as Preferred Clinical Specimen. J. Clin. Microbiol.
39: 1211-1216
[Abstract]
[Full Text]
-
Stevens, S. J. C., Verschuuren, E. A. M., Pronk, I., van der Bij, W., Harmsen, M. C., The, T. H., Meijer, C. J. L. M., van den Brule, A. J. C., Middeldorp, J. M.
(2001). Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood
97: 1165-1171
[Abstract]
[Full Text]
-
Jabs, W. J., Hennig, H., Kittel, M., Pethig, K., Smets, F., Bucsky, P., Kirchner, H., Wagner, H. J.
(2001). Normalized Quantification by Real-Time PCR of Epstein-Barr Virus Load in Patients at Risk for Posttransplant Lymphoproliferative Disorders. J. Clin. Microbiol.
39: 564-569
[Abstract]
[Full Text]
-
Clementi, M.
(2000). Quantitative Molecular Analysis of Virus Expression and Replication. J. Clin. Microbiol.
38: 2030-2036
[Full Text]